{
    "ticker": "TELA",
    "name": "Tela Bio, Inc.",
    "description": "Tela Bio, Inc. is a biotechnology company focused on developing innovative regenerative medicine products designed to improve patient outcomes in surgical procedures. Founded in 2015, Tela Bio is committed to addressing unmet medical needs through its proprietary technology platform that leverages the benefits of biologic materials. The company's flagship product, OviTex\u2122, is a biologic mesh that combines the structural support of traditional synthetic meshes with the regenerative properties of natural tissues, promoting healing and reducing complications. Tela Bio's products are designed for use in various surgical applications, including hernia repair, soft tissue reconstruction, and orthopedic procedures. The company aims to lead the way in the advancement of regenerative solutions in the surgical environment, striving to enhance the healing process while minimizing the risks associated with traditional surgical materials. With a focus on research and development, Tela Bio collaborates with leading healthcare professionals and institutions to continually innovate and refine its product offerings. The company's mission is to transform surgical care through the integration of advanced biologic technologies, ultimately improving the quality of life for patients.",
    "industry": [
        "Biotechnology",
        "Medical Devices"
    ],
    "headquarters": "Malvern, Pennsylvania, USA",
    "founded": "2015",
    "website": "https://www.telabio.com",
    "ceo": "Dan Pereira",
    "social_media": {
        "twitter": "https://twitter.com/TelaBio",
        "linkedin": "https://www.linkedin.com/company/tela-bio/"
    },
    "investor_relations": "https://investors.telabio.com",
    "key_executives": [
        {
            "name": "Dan Pereira",
            "position": "CEO"
        },
        {
            "name": "Peter O'Connor",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Regenerative Medicine Products",
            "products": [
                "OviTex\u2122"
            ]
        }
    ],
    "seo": {
        "meta_title": "Tela Bio, Inc. | Regenerative Medicine & Surgical Solutions",
        "meta_description": "Explore Tela Bio, Inc., a leader in regenerative medicine focused on innovative surgical solutions. Learn about our products and commitment to improving patient outcomes.",
        "keywords": [
            "Tela Bio",
            "Regenerative Medicine",
            "Surgical Solutions",
            "OviTex",
            "Biologics"
        ]
    },
    "faq": [
        {
            "question": "What is Tela Bio known for?",
            "answer": "Tela Bio is known for developing innovative regenerative medicine products, particularly the OviTex\u2122 biologic mesh."
        },
        {
            "question": "Who is the CEO of Tela Bio?",
            "answer": "Dan Pereira is the CEO of Tela Bio, Inc."
        },
        {
            "question": "Where is Tela Bio headquartered?",
            "answer": "Tela Bio is headquartered in Malvern, Pennsylvania, USA."
        },
        {
            "question": "What are Tela Bio's main products?",
            "answer": "Tela Bio's main product is the OviTex\u2122 biologic mesh, designed for various surgical applications."
        },
        {
            "question": "When was Tela Bio founded?",
            "answer": "Tela Bio was founded in 2015."
        }
    ],
    "competitors": [
        "ISRG",
        "TDOC",
        "MDT"
    ],
    "related_stocks": [
        "GILD",
        "AMGN",
        "VRTX",
        "ILMN"
    ]
}